All relevant data are within the paper.

Introduction {#sec005}
============

Radiation therapy has experienced an evolution from the 2-D approach to 3-D techniques, from conformal to intensity-modulated radiotherapy (IMRT), increasing the accuracy of dose delivery on the target volume and sparing the normal tissues. Due to this high conformity and rapid dose fallout outside the tumor a high geometric accuracy of the daily dose delivery is essential \[[@pone.0150326.ref001]\]. The introduction of image-guided radiation therapy (IGRT) allows a very accurate determination of the position of the clinical target volume (CTV) and organs at risk during the course of the treatment \[[@pone.0150326.ref002]\] and therefore has the potential to decrease the size of the planning target volume (PTV) to CTV margin in order to reduce the dose to normal tissue. There are multiple available image-guidance systems using ionization radiation or other technologies \[[@pone.0150326.ref003]\]. One frequently used system is kilovoltage cone-beam computer tomography (kV CBCT), which provides a 3-D visualization of the structures with soft tissue contrast \[[@pone.0150326.ref004], [@pone.0150326.ref005]\].

One important source of geometrical uncertainty in the radiotherapy process are interfractional setup errors during patient positioning which can be defined as a discrepancy between the anatomy of the patient at the planning CT and at the treatment. These errors can be divided into systematic errors (which are reproducible consistent errors, occurring in the same direction and magnitude) and random errors (which vary in direction and magnitude). Whereas the random errors blur the dose distribution, the systematic errors cause a shift of the cumulative dose distribution \[[@pone.0150326.ref006]\]. Because the interfractional setup errors play an important role for the overall treatment success, one major requirement during radiotherapy is to reduce these errors as far as possible and to introduce safety margins around the CTV to compensate for the remaining geometric uncertainties. However this safety margin, i.e. the CTV to PTV expansion is by definition occupied only by normal tissue. The aim of this work was to quantify the interfractional setup errors for different treatment sites guided by kV CBCT and suggest safety margins accordingly.

Methods and Materials {#sec006}
=====================

This study was approved by the local ethics committee / Institutional Review Board (IRB) (Medizinische Fakultät Mannheim, Medizinische Ethik-Kommission II) (2015-859R-MA). Written informed consent was given by the participants for retrospective anonymized analyses. In addition, the patient information was anonymized and de-identified before analysis.

Patient population and positioning based on kV CBCT {#sec007}
---------------------------------------------------

The data from 443 unselected patients treated in our institution between January 2013 and March 2014 with the following treatment sites were analyzed: prostate, prostate bed, cervix, rectum, anal, head and neck, brain and mediastinum. Prior to the treatment session a kV CBCT was performed for all patients at the treatment machine (Elekta, Sweden) in treatment position. The localization CBCT was matched with the original planning CT using bone matching and/or soft tissue-grey value matching followed by a manual correction if appropriate. The positioning correction vectors were calculated after the whole matching procedure including automated and manual user matching. and a translational isocenter correction by shifting the treatment couch was carried out.

Data analysis {#sec008}
-------------

The positioning translational vectors of each treatment session were collected from the record and verify system (Mosaiq 2.5, Elekta, Sweden) resulting in a total of 9504 kV CBCTs. The data for each treatment site is shown in detail in [Table 1](#pone.0150326.t001){ref-type="table"}. For each patient data set the individual average and standard deviation were calculated. Besides the total average the standard deviation, minimum and maximum value for each treatment site were computed. Additionally, the overall mean error (M), systematic error (Σ) and random error (σ) were determined according to van Herk's formalism: M is defined as the mean of all individual means, Σ corresponds to the standard deviation of all individual means, and σ is calculated through the root mean square of the individual standard deviations of all patients \[[@pone.0150326.ref006]\]. For prostate, prostate bed, head and neck, brain and mediastinum, in which the kV CBCTs were realized on a daily basis, the calculations were carried out also for the first 5 sessions. For cervix, rectum and anal the CBCT in our institution were done only once a week. Therefore, this first 5 fraction analysis was not performed for these treatment sites. Finally, a CTV-to-PTV margin expansion (if no image guidance system was used) was computed using van Herk's equation (2.5Σ + 0.7σ).

10.1371/journal.pone.0150326.t001

###### Number of patients and CBCTs per treatment site.

![](pone.0150326.t001){#pone.0150326.t001g}

  Treatment site   Number of patients   Number of CBCT
  ---------------- -------------------- ----------------
  Prostate         63                   1615
  Prostate Bed     51                   1339
  Cervix           16                   306
  Rectum           43                   339
  Anal             30                   235
  Head and Neck    99                   2851
  Brain            88                   1583
  Mediastinum      53                   1236
  Total            443                  9504

Results {#sec009}
=======

The average shifts and standard deviations for all the treatment sites in all three directions are shown in [Fig 1](#pone.0150326.g001){ref-type="fig"}.

![Average shifts and standard deviations for treatment sites in superior-inferior (SI), left-right (L-R) and anterior-posterior (A-P) direction.](pone.0150326.g001){#pone.0150326.g001}

The results of M, Σ and σ in all three directions are presented in [Table 2](#pone.0150326.t002){ref-type="table"} followed by a comparison with the results found in the literature \[[@pone.0150326.ref007]--[@pone.0150326.ref021]\]. For the systematic error, the largest value could be found in mediastinum on the three directions, whereas the smallest values were found in brain. For random error, the largest value was found for anal in the L-R direction (5.1mm), whereas the smallest values were also found in brain. In overall, the values were smaller than 5mm with a mean (SD) of 2.1 (0.7), 2.1 (0.5) and 2.5 (0.8)mm for the systematic error and 2.9 (0.9), 3.3 (1.2) and 3.2 (1.2)mm for the random error in superior--inferior (S-I), left-right (L-R) and anterior-posterior (A-P) direction, respectively.

10.1371/journal.pone.0150326.t002

###### Overall mean (M), systematic (Σ) and random setup errors (σ) / comparison with published data.

![](pone.0150326.t002){#pone.0150326.t002g}

  Treatment Site        n     CBCTs   Modality   M (mm)   Σ (mm)   σ (mm)                                 
  --------------------- ----- ------- ---------- -------- -------- -------- ----- ----- ----- ----- ----- -----
  **Prostate**                                                                                            
  Present study         63    1615    kV CBCT    -0.6     0.3      -1.1     2.5   2.6   2.9   3     3.9   3.9
  Wong *et al*.         329   1870    kV CT      n.d.     n.d.     n.d.     1.7   2.3   4.3   2.3   3.2   3.9
  Snir *et al*.         17    449     kV CBCT    0.4      -0.9     0.6      1.8   1.6   2.6   1.8   2.3   3
  Mayyas *et al*.       27    1100    kV CBCT    0.2      1.1      -1.2     2.7   2.4   3     2.2   2.5   3.2
  Qi *et al*.           36    957     kV CBCT    n.d.     n.d.     n.d.     1.8   1.8   2.1   2.3   2.1   2.8
                        36    1097    MV CT      n.d.     n.d.     n.d.     1.7   1.9   2.1   1.8   3.5   3.5
  **Prostate Bed**                                                                                        
  Present study         51    1339    kV CBCT    -0.4     -0.1     -1.5     1.7   2.2   2.6   2     3.6   3.1
  Ost *et al*.          15    547     kV CBCT    -0.5     1.5      1.7      2     2.7   2.7   1.5   2     2.3
  Huang *et al*.        14    420     kV CBCT    -0.9     0        1.9      1.3   1     2.5   3.1   1     3.1
  **Cervix**                                                                                               
  Present study         16    306     kV CBCT    -1       -0.3     0.4      2.8   2.3   3.2   3.4   4.6   3.9
  Santanam *et al*.     10    310     MV CT      -3       -1.3     1.3      4.6   2     1.5   4.8   3.4   3.7
  **Rectum**                                                                                               
  Present study         43    339     kV CBCT    0.8      0.1      2.8      1.6   2.1   2.5   3.1   2.9   3.8
  **Anal**                                                                                                 
  Present study         30    235     kV CBCT    -0.2     0.4      -1.8     1.7   2.1   2.5   3.7   5.1   4.8
  Chen *et al*.         20    365     MV CBCT    -2.3     2.1      1.1      3.2   3.6   1.1   2.9   5.5   3.8
  **Head and Neck**                                                                                       
  Present study         99    2851    kV CBCT    n.d.     n.d.     n.d.     1.9   1.4   1.7   2.3   2     2.2
  Den *et al*.          28    1013    kV CBCT    n.d.     n.d.     n.d.     1.1   1.1   1.4   2     1.5   1.9
  Velec *et al*.        11    338     kV CBCT    n.d.     n.d.     n.d.     1     0.8   1     1.5   1.5   1.6
  Qi *et al*.           29    632     kV CBCT    n.d.     n.d.     n.d.     1.8   1     1.2   1.6   1.4   1.4
                        35    974     MV CT      n.d.     n.d.     n.d.     2.3   1.2   1.1   1.7   1.7   1.7
                        53    1696    MV CBCT    n.d.     n.d.     n.d.     1.8   1.9   3     2.1   2     2
  **Brain**                                                                                                
  Present study         88    1583    kV CBCT    0.2      -0.1     -0.5     1     1.1   1     1.5   1.4   1.1
  Tryggestad *et al*.   20    462     kV CBCT    -0.5     0.6      -0.3     1.2   1     1.1   1.4   1.2   1.1
  **Mediastinum**                                                                                         
  Present study         53    1236    kV CBCT    1        0.6      -2.5     3.3   2.6   3.5   4.1   3.1   2.6
  Borst *et al*.        62    524     kV CBCT    -1.3     0        0.3      1.9   1.7   1.2   3.8   3.1   1.4
  Grills *et al*.       24    308     kV CBCT    n.d.     n.d.     n.d.     2.9   2     5.8   3.5   2.7   2
  Yeung *et al*.        13    389     kV CBCT    3.7      2.4      -2.4     5.6   3.5   3.2   4.6   3.7   4

Abbreviations: S-I = superior-inferior; L-R = left-right; A-P = anterior-posterior; n.d. = not determined.

A comparison of the overall treatment and the first 5 sessions is shown in [Table 3](#pone.0150326.t003){ref-type="table"}. It can be seen that the differences are smaller than 1mm. The largest differences were found in the systematic error in prostate (S-I direction) and prostate bed (L-R direction) with a value of 0.9mm. For the random error the largest value was found also in S-I direction of prostate (0.5mm).

10.1371/journal.pone.0150326.t003

###### Systematic and random setup errors for the total and first 5 sessions.

![](pone.0150326.t003){#pone.0150326.t003g}

  Treatment site   Direction   Σ (mm)   σ (mm)                     
  ---------------- ----------- -------- -------- ----- ----- ----- -----
  Prostate         S-I         2.5      3.4      0.9   3     2.5   0.5
                   L-R         2.6      3.3      0.7   3.9   3.8   0.1
                   A-P         2.9      3.7      0.8   3.9   3.6   0.3
  Prostate Bed     S-I         1.7      1.7      0     2     2.1   0.1
                   L-R         2.2      3.1      0.9   3.6   3.3   0.3
                   A-P         2.6      2.9      0.3   3.1   2.8   0.3
  Head and Neck    S-I         1.9      2.6      0.7   2.3   2.1   0.2
  L-R              1.4         1.7      0.3      2     1.8   0.2   
                   A-P         1.7      2        0.3   2.2   2     0.2
  Brain            S-I         1        1.2      0.2   1.5   1.4   0.1
                   L-R         1.1      1.3      0.2   1.4   1.4   0
                   A-P         1        1        0     1.1   1.1   0
  Mediastinum      S-I         3.3      3.7      0.4   4.6   4.4   0.2
                   L-R         2.6      3.2      0.6   3.7   3.7   0
                   A-P         3.5      3.4      0.1   4     3.6   0.4

Abbreviations: S-I = superior-inferior; L-R = left-right; A-P = anterior-posterior; Σ = systematic error; σ = random error; \|Diff\| = absolute value of the difference.

For each treatment site the calculated CTV-to-PTV expansion values for the overall sessions are presented in [Table 4](#pone.0150326.t004){ref-type="table"}. The largest values could be found for mediastinum and the smallest for brain. These results were expected because of the values of systematic and random errors computed previously.

10.1371/journal.pone.0150326.t004

###### Calculated clinical target volume (CTV) to planning target volume (PTV) margin expansion.

![](pone.0150326.t004){#pone.0150326.t004g}

  Treatment site    Direction (mm)         
  ----------------- ---------------- ----- ------
  Prostate          8.4              9.2   10
  Prostate Bed      5.7              8     8.7
  Cervix            9.4              9     10.7
  Rectum            6.2              7.3   8.9
  Anal              6.8              8.8   9.6
  Head and Neck     6.4              4.9   5.8
  Brain             3.6              3.7   3.3
  Mediastinum       11.5             9.1   11.6

Abbreviations: S-I = superior.inferior; L-R = left-right; A-P = anterior-posterior.

Discussion {#sec010}
==========

Interfraction setup errors for 8 different treatment sites were analyzed retrospectively using 9504 CBCT studies and a CTV-to-PTV margin expansion was proposed. The results showed that the variation was large for pelvis and thorax and small for head and neck treatments. This can be explained due to the use of immobilization devices for both head and neck and brain treatments and the presence of the skull in brain tumors which restricts the daily motion of the structures.

When analyzing the values for mean, systematic and random error, a larger value for M was found for rectum and mediastinum in the A-P direction. The mean value could deviate from zero due to some imprecisions in the setup procedure \[[@pone.0150326.ref006]\]. In our institution the rectum treatments are performed with the patient in prone position using a belly board whereas mediastinum in supine position with the arms up and a wing board. However, the values we obtained for mean, systematic and random error are similar to the values found in the literature.

For the cases where the values for the overall and the first 5 sessions were calculated, it can be seen that the differences are within the tolerance levels for geometrical alignment, i.e., less than 1mm \[[@pone.0150326.ref022]\], with the smallest differences were found in brain and the largest in prostate. Therefore, it is plausible to assume that the image guidance could be performed the first 5 sessions and the rest of the treatment with the skins or mask marks for selected cases. However, due to the highly precise radiation delivery required for IMRT treatments, there is a potential risk of overdose in the organs at risk, especially those adjacent to the PTV. Therefore, it is a clinical decision to assume the risk.

Because we analyzed a huge amount of data over a longer time period for different linacs we can not exclude that there was a recalibration of the CBCT performed between different datasets. However, whenever a CBCT recalibration is performed it is guaranteed that the original accuracy according to the acceptance procedure of the linac and the CBCT system is restored. The recalibration is performed with a standard ball bearing phantom. During the calibration procedure the small spherical phantom is even positioned with an accuracy of few tenths of a millimetre (mostly \~0.2mm) in the MV isocenter before the new flexmaps of the CBCT and the kV isocenter are defined. Therefore the magnitude of a deviation before and after the recalibration (introduction of a new systematic error) of the CBCT system is in submillimeter range and was not separately taken into account.

One limitation of this study is that it does not account for residual errors because a second (verification) CBCT scan after the repositioning was not carried out. In other studies, for prostate bed \[[@pone.0150326.ref011]\] and head and neck \[[@pone.0150326.ref023]\] the residual errors were determined by performing a second CBCT after the treatment and matching it with the planning CT. Of course this procedure will also lead to a higher dose exposure to the patient. The assessment of the residual errors will allow to calculate CTV-to-PTV expansion margins when image guidance is used which should in general be smaller than the values obtained in this study. Because safety margins are usually applied in three dimensions even a small reduction can result in a considerably reduced normal tissue volume.

Conclusions {#sec011}
===========

The systematic and random errors found in this work using IGRT in a clinical routine setup were not larger than 5mm for the different treatment sites. When the overall treatment is compared with the first 5 sessions the results for the interfraction positioning errors do not show a large variability. Besides, the CTV-to-PTV margin expansions were calculated based on a large number of CBCT based repositioning vectors. The margins were not larger than 12mm, similar to literature values and thus confirming previous studies. A future work could be initiated to assess the residual errors after position correction to suggest reduced margins when IGRT is performed.
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